This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Frontiers in HIV Pathogenesis, Therapy and Eradication
joint with Cell Biology of Virus Entry, Replication and Pathogenesis
Organizer(s): Alan N. Engelman, Eric O. Freed and John M. Coffin
Date: March 26 - 31, 2012
Location: Whistler Conference Centre, Whistler, BC, Canada
Part of the Keystone Symposia Global Health Series, Supported by the Bill & Melinda Gates Foundation. Sponsored by Sangamo BioSciences, Inc.
Summary of Meeting:
AIDS is incurable because cells latently infected with HIV resist antiviral therapy. Topical to the discussion of HIV eradication is the biology behind latent infection as well as models for the study of latency and pharmacological approaches to stimulate proviral gene expression. The Keystone Symposia meeting on Frontiers in HIV Pathogenesis, Therapy and Eradication will create an environment for free exchange of ideas and cutting-edge results from a range of scientists in academia and industry in the fields of HIV pathogenesis, pharmacology and eradication. Joint plenary sessions with the concurrent meeting on Cell Biology of Virus Entry, Replication and Pathogenesis will highlight common topics of interest including mechanisms of virus entry and inhibition, and will significantly enhance opportunities for interdisciplinary interactions. Leaders from the HIV replication and drug resistance fields will critically examine the state of antiviral therapy, novel inhibitors and important virus-host interactions. Speakers selected from submitted abstracts will fill out workshops on pharmacological approaches and the cell biology of HIV infection.
Global Health Travel Award Deadline: October 25 2011
Scholarship Deadline: November 29 2011
Discounted Abstract Deadline: November 29 2011
Abstract Deadline: January 4 2012
Discounted Registration Deadline: January 26 2012
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Bill & Melinda Gates FoundationSangamo BioSciences, Inc.
We gratefully acknowledge additional support for this conference from:
Biogen IdecOffice of AIDS Research, NIH
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Merck Research Laboratories
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI098442-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found